Wilson; Maria E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wilson; Maria E..The latest application filed is for "heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders".

Company Profile

1.9.13

Wilson; Maria E. - San Francisco CA
- San Francisco CA US
Wilson; Maria E. - Hayward CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 9,925,189 - Chen , et al. March 27, 2	2018-03-27
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20180021335 - Chen; Xin ; et al.	2018-01-25
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 9,737,537 - Chen , et al. August 22, 2	2017-08-22
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20170105993 - Chen; Xin ; et al.	2017-04-20
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20150239881 - Chen; Xin ; et al.	2015-08-27
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,975,258 - Chen , et al. March 10, 2	2015-03-10
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,921,350 - Chen , et al. December 30, 2	2014-12-30
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 08921350 -	2014-12-30
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20140024830 - Chen; Xin ; et al.	2014-01-23
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20130281691 - Chen; Xin ; et al.	2013-10-24
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,288,384 - Chen , et al. October 16, 2	2012-10-16
2,4-disubsituted thiazoles and pharmaceutical compositions thereof Grant 8,227,495 - Chen , et al. July 24, 2	2012-07-24
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20100130511 - CHEN; XIN ; et al.	2010-05-27
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20100087465 - Chen; Xin ; et al.	2010-04-08
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-- yl}-pyrimidine Grant 7,638,541 - Chen , et al. December 29, 2	2009-12-29
Oxymethylene Aryl Compounds And Uses Thereof App 20090270404 - Wilson; Maria E. ; et al.	2009-10-29
CD39L3 and its role in diabetes Grant 7,556,930 - Johnson , et al. July 7, 2	2009-07-07
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20090054475 - Chen; Xin ; et al.	2009-02-26
CD39L3 and its role in diabetes App 20060246006 - Johnson; Jeffrey D. ; et al.	2006-11-02
Compositions and methods of using hexokinase V App 20050186582 - Johnson, Jeffrey D. ; et al.	2005-08-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.